USPSTF finds evidence lacking for sleep apnea screening

June 15, 2016

(HealthDay)—The U.S. Preventive Services Task Force (USPSTF) has found insufficient evidence for the benefit of obstructive sleep apnea (OSA) screening in asymptomatic populations. These findings form the basis of a draft recommendation statement, published online June 14 by the USPSTF.

Daniel E. Jonas, M.D., M.P.H., from the RTI International-University of North Carolina at Chapel Hill in Research Triangle Park, and colleagues conducted a systematic review of the evidence for screening and treating asymptomatic adults or those with unrecognized symptoms for OSA. Data were included from 110 studies.

The researchers found that none of the compared screening with no screening. There was inadequate direct evidence on the benefit of screening in asymptomatic populations. No studies assessed the effect of screening on . Based on these findings, the USPSTF concluded that the evidence is currently insufficient to weigh the balance of benefits and harms of OSA screening in asymptomatic adults (I statement). The draft recommendation statement has been posted for public comment from June 14 to July 11, 2016.

"The Task Force is calling for more research on whether screening in adults without known symptoms leads to improvements in health outcomes such as heart attacks, strokes, quality of life, and mortality," Task Force member Alex H. Krist, M.D., M.P.H., said in a statement.

Explore further: USPSTF draft recommendation urges against COPD screening

More information: Evidence Review
Draft Recommendation Statement
Comment on Recommendations

Related Stories

USPSTF draft recommendation urges against COPD screening

August 18, 2015
(HealthDay)—The U.S. Preventive Services Task Force (USPSTF) has found no net benefit for chronic obstructive pulmonary disease (COPD) screening in asymptomatic adults and consequently recommends against screening. These ...

USPSTF: Insufficient evidence for visual skin cancer screening

December 2, 2015
(HealthDay)—The U.S. Preventive Services Task Force has found that there is currently insufficient evidence to weigh the benefits and harms of visual skin cancer screening in adults. These findings form the basis of a draft ...

USPSTF finds evidence lacking for autism screening in children

August 4, 2015
(HealthDay)—The U.S. Preventive Services Task Force (USPSTF) has concluded that there is currently insufficient evidence to assess the benefits and harms of screening for autism spectrum disorder (ASD) in asymptomatic children ...

USPSTF: more evidence needed for visual acuity screening

July 21, 2015
(HealthDay)—The U.S. Preventive Services Task Force (USPSTF) has concluded that there is currently insufficient evidence to assess the benefits and harms of screening for impaired visual acuity in older adults. These findings ...

USPSTF recommends CRC screening for 50- to 75-year-olds

October 6, 2015
(HealthDay)—The U.S. Preventive Services Task Force (USPSTF) recommends colorectal cancer (CRC) screening starting at age 50 years and continuing through age 75 years. These findings form the basis of a draft recommendation ...

Benefits of thyroid screening unclear

October 27, 2014
Researchers for the U.S. Preventive Services Task Force (USPSTF) suggest that more research is needed to determine the benefits of screening asymptomatic individuals for thyroid dysfunction. Their review is being published ...

Recommended for you

Sleep deficiency increases risk of a motor vehicle crash

April 4, 2018
Excessive sleepiness can cause cognitive impairments and put individuals at a higher risk of motor vehicle crash. However, the perception of impairment from excessive sleepiness quickly plateaus in individuals who are chronically ...

Sleep apnea study finds male-female differences in cerebral cortex thickness, symptoms

March 13, 2018
Researchers from the UCLA School of Nursing examined clinical records and magnetic resonance imaging brain scans of patients who were recently diagnosed with sleep apnea, and discovered several apparent connections between ...

Synthetic cannabinoid reduces sleep apnea

November 29, 2017
A synthetic version of a molecule found in the cannabis plant was safe and effective in treating obstructive sleep apnea in the first large, multi-site study of a drug for the sleep disorder funded by the National Institutes ...

Sleeping through the snoring: Researchers identify neurons that rouse the brain to breathe

November 2, 2017
A common and potentially serious sleep disorder, obstructive sleep apnea affects at least one quarter of U.S. adults and is linked to increased risk of diabetes, obesity and cardiovascular disease. In a paper published today ...

Remede system approved for sleep apnea

October 9, 2017
(HealthDay)—The Remede sleep system, an implanted device that treats central sleep apnea by activating a nerve that sends signals to the diaphragm to stimulate breathing, has been approved by the U.S. Food and Drug Administration.

Inflammation may precede sleep apnea, could be treatment target

September 1, 2017
Inflammation is traditionally thought of as a symptom of sleep apnea, but it might actually precede the disorder, potentially opening the door for new ways to treat and predict sleep apnea, according to researchers.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.